Malignant Solid Neoplasm Clinical Trials

ReadTheTrial indexes 2 studies for Malignant Solid Neoplasm. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Malignant Solid Neoplasm.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials for Malignant Solid Neoplasm

A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients With Inoperable Malignant Central Airway Obstruction

NCT06306638 · RECRUITING · Phase 2

MATCH Treatment Subprotocol J: Trastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification

NCT06136897 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Malignant Solid Neoplasm?

There are 2 clinical trials listed for Malignant Solid Neoplasm. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Malignant Solid Neoplasm trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Malignant Solid Neoplasm trials in?

Current Malignant Solid Neoplasm trials are distributed across: Phase 2 (2).

Find More Trials